SCHEMBL8485493

SCHEMBL8485493

CC(=O)N(Nc1ccc(-c2ccccc2)cc1)c1ccccc1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ GLA P06280 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ CDC25B P30305 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ DHODH Q02127 5/20 0.41
▸ ACLY P53396 1/20 0.41
▸ MAPT P10636 2/20 0.41
▸ PTPN1 P18031 2/20 0.39
▸ PTPN11 Q06124 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ HNF4A P41235 2/20 0.38
▸ ACMSD Q8TDX5 2/20 0.38
▸ DHFR P00374 1/20 0.38
▸ MCL1 Q07820 1/20 0.38
▸ LTB4R2 Q9NPC1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8479733 0.91 ALDH1A1 (0.45) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL8479485 0.87 ALDH1A1 (0.49) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL8606406 0.86 LMNA (0.48) ALDH1A1GAAHPGDMAPTNPC1
SCHEMBL8855171 0.79 HTT (0.45) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL8608850 0.75 KDM4E (0.43) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL9093965 0.74 KEAP1 (0.41) ALDH1A1GAAHPGDDHODHMAPT
SCHEMBL9094581 0.74 GRIK1 (0.48) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL9094525 0.74 KDM4E (0.46) ALDH1A1KDM4EGLAGAAHPGD
SCHEMBL5696478 0.71 CDC25B (0.41) ALDH1A1KDM4EGAAHPGDCDC25B
SCHEMBL9094620 0.70 PBRM1 (0.41) ALDH1A1KDM4EGLAGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5925647-A TREATMENT OF INSULIN NON-INSULIN DEPENDENT DIABETES SHAMAN PHARMACEUTICALS, INC. (US) 1999-07-20 — — US disclosed
US-5681958-A TREATMENT OF DIABETES SHAMAN PHARMACEUTICALS, INC. (US) 1997-10-28 — — US disclosed
WO-1996010015-A1 CRYPTOLEPINE ANALOGS WITH HYPOGLYCEMIC ACTIVITY SHAMAN PHARMACEUTICALS, INC. (US) 1996-04-04 — — WO disclosed
Send feedback